Blood

Haplo + 4 Kids- Recruiting

Evaluation of efficacy, outcomes and safety of CD45RO+ memory T cell add-back following haematopoietic cell transplantation in paediatric patients with primary immunodeficiency disorder.

• Study stage: Recruiting
• Sponsor: Newcastle upon Tyne Hospitals NHS Foundation Trust
• Funder: MRC
• Therapeutic area: Blood
• Type of study: CTIMP

Primary outcome: To determine the optimal dose of CD45RO+ memory T-cell addback in children with non-SCID IEI after TCRαβ-HaploSCT.